Literature DB >> 24912180

IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.

Fella Tamzalit1, Isabelle Barbieux1, Ariane Plet1, Julie Heim1, Steven Nedellec2, Sébastien Morisseau3, Yannick Jacques1, Erwan Mortier4.   

Abstract

Interleukin (IL)-15 and its specific receptor chain, IL-15Rα, support the development of various effector cells, including NK and CD8 T cells via a mechanism called trans-presentation. Whereas the dynamic of trans-presentation has been shown to involve the recycling of IL-15Rα by presenting cells, the way responding cells integrate, or take advantage of this process has not been evaluated yet. To address this question, we set up a trans-presentation model using a membrane-bound IL-15.IL-15Rα fusion protein, and found that IL-15 is detectable within responding cells following IL-15 trans-presentation. The role of the proteolytic cleavage of IL-15Rα in this process was investigated by generating an uncleavable form of IL-15Rα. We showed that IL-15 entry into responding cells necessitates the cleavage of IL-15.IL-15Rα complex from the surface of IL-15 presenting cells, and observed that IL-15Rα cleavage is associated with a decrease of the duration of Stat5 signaling. Once separated from presenting cells, responding cells are able to recycle IL-15.IL-15Rα complexes via intracellular compartments, for residual proliferation in a time-limited manner. These studies define an unprecedented cytokine pathway in which the IL-15.IL-15Rα complex cleaved from presenting cells allows responding cells to internalize, store and use IL-15.IL-15Rα complex for their own proliferation and survival.

Entities:  

Keywords:  IL-2Rβ; autocrine; cell–cell interaction; lymphocyte; synapse

Mesh:

Substances:

Year:  2014        PMID: 24912180      PMCID: PMC4060713          DOI: 10.1073/pnas.1405514111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist.

Authors:  Erwan Mortier; Jérôme Bernard; Ariane Plet; Yannick Jacques
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

2.  Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.

Authors:  Xinquan Wang; Mathias Rickert; K Christopher Garcia
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

3.  Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site.

Authors:  N Azimi; K Brown; R N Bamford; Y Tagaya; U Siebenlist; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.

Authors:  N Azimi; S Jacobson; T Leist; T A Waldmann
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

5.  The structure of interleukin-2 complexed with its alpha receptor.

Authors:  Mathias Rickert; Xinquan Wang; Martin J Boulanger; Natalia Goriatcheva; K Christopher Garcia
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

Review 6.  IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2.

Authors:  J G Giri; D M Anderson; S Kumaki; L S Park; K H Grabstein; D Cosman
Journal:  J Leukoc Biol       Date:  1995-05       Impact factor: 4.962

7.  A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  J D Burton; R N Bamford; C Peters; A J Grant; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.

Authors:  J Müllberg; W Oberthür; F Lottspeich; E Mehl; E Dittrich; L Graeve; P C Heinrich; S Rose-John
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

9.  Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.

Authors:  J G Giri; S Kumaki; M Ahdieh; D J Friend; A Loomis; K Shanebeck; R DuBose; D Cosman; L S Park; D M Anderson
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

10.  Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.

Authors:  Patrick R Burkett; Rima Koka; Marcia Chien; Sophia Chai; David L Boone; Averil Ma
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

View more
  27 in total

1.  IL-15 regulates fibrosis and inflammation in a mouse model of chronic pancreatitis.

Authors:  Murli Manohar; Hemanth Kumar Kandikattu; Alok Kumar Verma; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-09-13       Impact factor: 4.052

2.  Trans-endocytosis of intact IL-15Rα-IL-15 complex from presenting cells into NK cells favors signaling for proliferation.

Authors:  Olga M Anton; Mary E Peterson; Michael J Hollander; David W Dorward; Gunjan Arora; Javier Traba; Sumati Rajagopalan; Erik L Snapp; K Christopher Garcia; Thomas A Waldmann; Eric O Long
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

3.  CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans.

Authors:  Adam T Waickman; Davinna L Ligons; SuJin Hwang; Joo-Young Park; Vanja Lazarevic; Noriko Sato; Changwan Hong; Jung-Hyun Park
Journal:  Cytokine       Date:  2017-08-12       Impact factor: 3.861

4.  Astrocytes fuel the fire of lymphocyte toxicity after stroke.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-06       Impact factor: 11.205

5.  Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.

Authors:  Rashmi Gupta; Xiao J Yan; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

6.  IL-15-deficient mice develop enhanced allergic responses to airway allergen exposure.

Authors:  C B Mathias; C M Schramm; L A Guernsey; C A Wu; S H Polukort; J Rovatti; J Ser-Dolansky; E Secor; S S Schneider; R S Thrall; H L Aguila
Journal:  Clin Exp Allergy       Date:  2017-02-07       Impact factor: 5.018

7.  Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys.

Authors:  Nicolas Huot; Beatrice Jacquelin; Thalia Garcia-Tellez; Philippe Rascle; Mickaël J Ploquin; Yoann Madec; R Keith Reeves; Nathalie Derreudre-Bosquet; Michaela Müller-Trutwin
Journal:  Nat Med       Date:  2017-10-16       Impact factor: 53.440

Review 8.  Control of memory CD8+ T cell longevity and effector functions by IL-15.

Authors:  Jeffrey C Nolz; Martin J Richer
Journal:  Mol Immunol       Date:  2019-12-06       Impact factor: 4.407

9.  Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.

Authors:  Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

Review 10.  Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.

Authors:  Theofanis Floros; Ahmad A Tarhini
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.